Form 4: Tenaya CMO Sells Shares for Tax Obligations

Tenaya Therapeutics' Chief Medical Officer, Tingley Whittemore, sold 5,053 shares of common stock at a weighted average price of $1.253 to cover tax withholding obligations related to RSU vesting.

Summary

• Chief Medical Officer Tingley Whittemore of Tenaya Therapeutics, Inc. sold 5,053 shares of common stock.
• The sales occurred on August 18, 2025, at a weighted average price of $1.253 per share, with prices ranging from $1.18 to $1.32.
• These transactions were conducted to cover tax withholding obligations arising from the vesting of restricted stock units (RSUs) awarded on February 15, 2023, February 23, 2024, and January 24, 2025.
• Following these transactions, Tingley Whittemore beneficially owns 172,803 shares of Tenaya Therapeutics, Inc. common stock.
• The beneficial ownership includes 93,757 shares that will be issued upon vesting of restricted stock units and 6,000 shares acquired via the 2021 Employee Stock Purchase Plan on June 10, 2025.
• The transactions were made pursuant to a Rule 10b5-1 trading plan.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction (sale of shares to cover tax withholding obligations upon RSU vesting) which is a neutral event and does not indicate a change in company fundamentals or management's confidence beyond standard compensation practices.

Positives

• Vesting of restricted stock units indicates continued employee retention and compensation.

Negatives

• The sale of shares, even for tax purposes, slightly increases the public float.

Future Outlook

No specific future outlook or guidance is provided in this insider transaction report.

Industry Context

This is a routine insider transaction, specifically a sale of shares to cover tax obligations related to RSU vesting, which is a common practice in executive compensation across various industries, including biotechnology. It does not reflect broader industry trends or competitive dynamics.

Stakeholder Impact

• Shareholders: Minimal direct impact as it is a small, routine sale for tax purposes.
• Employees: Indicates the vesting of RSUs, which is a positive for employee compensation.

Key Dates

Recommendation

The filing details a routine sale of shares by a company officer to cover tax obligations associated with the vesting of restricted stock units. This type of transaction is common and does not typically reflect a change in the officer's confidence in the company's future prospects or fundamental performance. Therefore, it does not provide new information that would alter an existing investment thesis, warranting a 'hold' recommendation.

Keywords

Tenaya Therapeutics, TNYA, SEC Form 4, Insider Trading, Stock Sale, Restricted Stock Units, RSU Vesting, Tax Withholding, Chief Medical Officer, Biotechnology, Pharmaceuticals, Corporate Governance, Rule 10b5-1